V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006258 | 10004063 | 1.75 | 70.2 | Adjuvant (A) | 2018-03-31 | 2018-03-31 | CARBOPLATIN + PACLITAXEL | 2 | N | 10375765 | CARBOPLATIN + PACLITAXEL |
| 10006259 | 10007142 | 0 | 72 | Palliative (P) | 2014-12-15 | 2014-12-19 | Carboplatin + Etoposide IV 3 day | 2 | null | 10375783 | CARBOPLATIN + ETOPOSIDE |
| 10006260 | 10007142 | 1.77 | 84.6 | null | 2018-04-15 | 2018-04-16 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10375783 | ABIRATERONE |
| 10006261 | 10004064 | 1.61 | 72 | Palliative (P) | 2018-03-01 | 2018-03-11 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | null | 10376164 | FLUOROURACIL |
| 10006262 | 10004066 | 1.6 | 65.9 | Palliative (P) | null | 2017-05-19 | Carboplatin + Pemetrexed | N | N | 10376227 | GEMCARBO |
| 10006263 | 10004067 | 1.77 | 78 | Palliative (P) | null | 2015-01-07 | FLUOROURACIL + FOLINIC ACID | null | Y | 10376707 | CARBOPLATIN + VINORELBINE |
| 10006264 | 10004067 | 1.62 | 63.7 | Adjuvant (A) | 2015-07-16 | 2015-07-16 | Trial Unspecified | N | N | 10376707 | TRIAL |
| 10006265 | 10004067 | 1.8 | 81.85 | Palliative (P) | 2015-08-22 | 2015-11-16 | LENALIDOMIDE | N | N | 10376707 | LENALIDOMIDE |
| 10006266 | 10004069 | null | null | Adjuvant (A) | 2017-05-28 | 2017-09-04 | null | null | N | 10376865 | IBRUTINIB |
| 10006267 | 10004070 | 1.77 | 77.7 | Disease modification (D) | 2017-10-13 | 2017-10-13 | BCG Intravesical | N | N | 10377105 | CARBOPLATIN + PEMETREXED |
| 10006268 | 10004072 | 1.78 | 71 | Adjuvant (A) | 2018-12-29 | 2019-01-19 | Capecitabine | 02 | N | 10377105 | CAPECITABINE |
| 10006269 | 10004074 | 1.66 | 101 | Adjuvant (A) | 2015-04-28 | 2015-06-28 | Capecitabine | 02 | N | 10377452 | CAPECITABINE |
| 10006270 | 10004075 | 1.69 | 72.3 | Palliative (P) | 2017-10-27 | 2017-10-29 | Capecitabine | 2 | N | 10377488 | CAPECITABINE |
| 10006271 | 10004078 | null | 99 | Palliative (P) | 2016-09-01 | 2016-09-01 | CARBOPLATIN | 2 | N | 10377488 | GEMCARBO |
| 10006272 | 10008417 | 1.79 | 59 | Palliative (P) | 2018-01-09 | 2018-03-15 | CVP R | N | N | 10377772 | BEVACIZUMAB |
| 10006273 | 10004079 | 1.68 | 95 | Adjuvant (A) | 2018-04-06 | 2018-05-06 | Trial Unspecified | 02 | N | 10377820 | TRIAL |
| 10006274 | 10004080 | 1.47 | 63 | Adjuvant (A) | 2017-03-21 | 2017-03-21 | Carboplatin + Pemetrexed | 2 | N | 10377922 | CVP R |
| 10006275 | 10004080 | 1.69 | 58.8 | Curative (C) | 2018-09-30 | 2018-10-01 | IBRUTINIB | 02 | N | 10377922 | LENALIDOMIDE |
| 10006276 | 10004081 | 1.63 | 79.4 | Palliative (P) | 2018-11-17 | 2018-11-17 | Abiraterone | N | N | 10378220 | FLUOROURACIL |
| 10006277 | 10004082 | 1.9 | 0 | null | 2019-07-24 | 2019-07-27 | Temozolomide 150mg/m2 | N | N | 10378293 | TEMOZOLOMIDE |
| 10006278 | 10004085 | 0 | 92 | Not known (9) | 2014-11-03 | 2014-11-13 | CARBOPLATIN + GEMCITABINE | 02 | N | 10378613 | PEMETREXED |
| 10006279 | 10004086 | 1.68 | 70 | Palliative (P) | 2019-07-02 | 2019-07-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10378970 | BENDAMUSTINE + RITUXIMAB |
| 10006280 | 10004088 | null | 59.8 | Disease modification (D) | 2018-06-23 | 2018-06-26 | Carboplatin + Pemetrexed | N | N | 10378986 | BCG |
| 10006281 | 10004089 | 1.63 | 82.4 | Palliative (P) | 2015-02-05 | 2015-02-06 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 10379009 | FLUOROURACIL |
| 10006282 | 10004090 | 1.81 | 91.9 | Adjuvant (A) | 2018-05-07 | 2018-05-21 | Capecitabine | N | N | 10379009 | CAPECITABINE |
| 10006283 | 10004091 | 1.76 | 74 | Palliative (P) | 2018-01-30 | 2018-01-30 | Capecitabine | N | N | 10379515 | CAPECITABINE |
| 10006284 | 10004093 | null | 70.5 | Adjuvant (A) | 2015-06-30 | 2015-06-30 | CARBOPLATIN + FLUOROURACIL + Trastuzumab | N | N | 10379596 | CTD |
| 10006285 | 10004096 | 1.65 | 63.5 | Palliative (P) | 2018-07-15 | 2018-07-16 | CARBOPLATIN | N | N | 10379614 | GEMCITABINE |
| 10006286 | 10004097 | 1.76 | 69.45 | Palliative (P) | 2018-03-15 | 2018-03-15 | Carboplatin + Pemetrexed | N | N | 10379614 | CARBOPLATIN |
| 10006287 | 10004099 | 1.63 | 94.5 | Palliative (P) | 2015-01-28 | 2015-01-28 | Carboplatin + Etoposide iv&po | 2 | null | 10379707 | CARBOPLATIN + ETOPOSIDE |
| 10006288 | 10004099 | 0 | 107 | Palliative (P) | 2018-02-21 | 2018-02-21 | BENDAMUSTINE + RITUXIMAB | 2 | N | 10379707 | BENDAMUSTINE + RITUXIMAB |
| 10006289 | 10004100 | 1.74 | 70.5 | Palliative (P) | 2018-06-05 | 2018-06-11 | Carboplatin + Etoposide IV 3 day | N | N | 10380108 | CARBOPLATIN + ETOPOSIDE |
| 10006290 | 10004101 | 1.63 | 72 | Palliative (P) | 2017-10-17 | 2017-10-26 | BENDAMUSTINE + RITUXIMAB | N | N | 10380124 | BENDAMUSTINE + RITUXIMAB |
| 10006291 | 10004104 | 1.74 | 78.4 | Palliative (P) | 2013-12-29 | 2014-03-24 | Capecitabine | 2 | N | 10380124 | CAPECITABINE |
| 10006292 | 10004108 | 1.81 | 62.3 | Adjuvant (A) | 2017-07-13 | 2017-07-13 | FLUOROURACIL | N | N | 10380173 | NOT MATCHED |
| 10006293 | 10004112 | 1.7 | 63.7 | Palliative (P) | 2014-09-30 | 2014-10-01 | Bendamustine+Rituximab (1st Course) | N | N | 10380355 | BENDAMUSTINE + RITUXIMAB |
| 10006294 | 10004114 | null | 55.2 | Palliative (P) | 2017-01-10 | 2017-08-15 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10380397 | CARBOPLATIN + PEMETREXED |
| 10006295 | 10007162 | 1.7 | null | Palliative (P) | 2015-11-22 | 2015-11-22 | R GCVP | 2 | Y | 10380457 | CARBOPLATIN |
| 10006296 | 10004116 | 1.64 | 138 | Palliative (P) | 2016-04-02 | 2016-08-15 | GEMCARBO | N | Y | 10380618 | NOT MATCHED |
| 10006297 | 10004118 | 1.8 | 76.3 | Palliative (P) | 2015-05-15 | 2015-05-15 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10380618 | BENDAMUSTINE + RITUXIMAB |
| 10006298 | 10004118 | 1.71 | 60.1 | Adjuvant (A) | 2019-07-12 | 2019-08-06 | CARBOPLATIN + VINORELBINE | 02 | N | 10380618 | BCG |
| 10006299 | 10004118 | 1.73 | 82 | Palliative (P) | null | 2018-02-13 | Azacitidine | N | N | 10380618 | AZACITIDINE |
| 10006300 | 10004120 | 1.73 | 75.1 | null | 2017-11-15 | 2017-12-05 | Carboplatin + Etoposide iv&po | 02 | N | 10381135 | CARBOPLATIN + ETOPOSIDE |
| 10006301 | 10004121 | 1.65 | 93 | Adjuvant (A) | 2016-03-11 | 2016-03-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | 10381172 | CARBOPLATIN |
| 10006302 | 10004121 | 1.6 | 76 | Curative (C) | 2017-02-26 | 2018-02-25 | IBRUTINIB | N | N | 10381172 | BCG |
| 10006303 | 10004121 | 1.8 | 93.1 | Palliative (P) | 2017-05-12 | 2017-05-17 | BCG Intravesical | N | N | 10381172 | CARBOPLATIN |
| 10006304 | 10004122 | 1.56 | 63.1 | Curative (C) | 2017-03-11 | 2017-03-15 | FLUOROURACIL | N | N | 10381565 | IBRUTINIB |
| 10006305 | 10004123 | 1.65 | 87 | Palliative (P) | 2017-10-12 | 2017-11-09 | CARBOPLATIN + ETOPOSIDE | 02 | N | 10381987 | CARBOPLATIN + ETOPOSIDE |
| 10006306 | 10004123 | 1.67 | null | Palliative (P) | 2017-08-19 | 2017-11-25 | BENDAMUSTINE + RITUXIMAB | N | N | 10381987 | BENDAMUSTINE + RITUXIMAB |
| 10006307 | 10008932 | 1.7 | 72.3 | Adjuvant (A) | 2018-09-13 | 2018-09-20 | Bevacizumab | 2 | N | 10382154 | BEVACIZUMAB |